About
BioChange has developed a breakthrough technology for tissue regeneration. A unique injectable scaffold that stimulates tissue repair and remodelling at the injected site. The scaffold is based on natural biomaterials designed for implantation using a minimally invasive procedure. It mimics the healthy Extra Cellular Matrix (ECM) and triggers the body to repair itself. Multiple long-term animal studies confirmed the safety and efficacy of the technology. The company is now selling products in the veterinary market and in tissue engineering research and is committed to start first clinical study in aesthetic dermatology in 2022. Several other products based on the CellFoam platform technology are in development to enrich our pipeline.
Tags
Total Employees
11
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
35Traction
11Team
30Visibility
28Profile
70Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does BioChange do?
BioChange has developed a breakthrough technology for tissue regeneration. A unique injectable scaffold that stimulates tissue repair and remodelling at the injected site. The scaffold is based on natural biomaterials designed for implantation using a minimally invasive procedure. It mimics the healthy Extra Cellular Matrix (ECM) and triggers the body to repair itself. Multiple long-term animal studies confirmed the safety and efficacy of the technology. The company is now selling products in th…
When was BioChange founded?
BioChange was founded in 2017.
What industry does BioChange operate in?
BioChange operates in Dermatology, Healthcare.
How many employees does BioChange have?
BioChange has approximately 11 people on record.